Fig. 3. Effects of LJE and leonurine on the diameters of L6 myotubes.

L6 myotubes were treated with TNF-α (50 ng/ml), LJE (40 and 80 μg/ml), and leonurine (20 and 40 μM). Relative myotube diameters were measured (A, B). Group differences were assessed by Duncan’s multiple range test, ##p < 0.01 (negative control group vs. TNF-α-treated group), **p < 0.01 (TNF-α-treated group vs. LJE- and leonurine-treated groups).